The molecular mechanisms underlying the changes in the nigrostriatal pathway in Parkinsons disease (PD) are not completely understood. whether the protein displayed significant abundance changes following each neurotoxin treatment. A two-sample test was applied to detect abundance differences between the two models. A protein is considered to have a significant abundance change when the protein… Continue reading The molecular mechanisms underlying the changes in the nigrostriatal pathway in